SkinBioTherapeutics had a revenue of 1.58M in the quarter ending Dec 31, 2024, with 43.10%. This bring the company's revenue in the last twelve months to 2.68M, Decreased 121.67%. In the fiscal year ending Jun 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M with 815.51% growth.